Indazoles, Benzothiazoles, Benzoisothiazoles, Benzisoxazoles, and Preparation and Uses Thereof
IL205680D0
Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders
US2010056491A1
4'-amino cyclic compounds having 5-ht6 receptor affinity
US2010056531A1
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
US2010029629A1
Acyclic compounds having 5-ht6 receptor affinity
US2010029689A1
Phosphodiesterase 4 inhibitors
US2010022581A1
Pyrrolidine-substituted azaindole compounds having 5-ht6 receptor affinity
US2010016297A1
Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
CN101910170A
(1,4-diazabicyclo [3.2.2] ninth of the ten Heavenly Stems-6-alkene-4-yl)-heterocyclic radical-ketone part that is used for the treatment of the nicotinic acetylcholine receptor of disease
WO2009051922A1
Methods of treating alzheimer's disease with (+) - isopropyl 2-methoxyethyl 4-(2-chloro-3- cyano-phenyl) -1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylate and a cholinesterase inhibitor
MX2010001576A
3' substituted compounds having 5-ht6 receptor affinity.
AU2008256859A1
4' substituted compounds having 5-HT6 receptor affinity
WO2008109343A1
Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith with (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
EP2121603A2
6' substituted indole and indazole derivatives having 5-ht6 receptor affinity
WO2008058234A2
Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility
AU2007221049A1
Cinnoline and quinazoline derivates as phosphodiesterase 10 inhibitors
AU2007217474A1
Cinnoline derivatives as phosphodiesterase 10 inhibitors
WO2007098418A1
Compounds having 5-ht6 receptor affinity
KR20080067339A
1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
SG165417A1
Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
